We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$41.2B
AUM Growth
+$3.27B
Cap. Flow
-$186M
Cap. Flow %
-0.45%
Top 10 Hldgs %
40.32%
Holding
737
New
74
Increased
253
Reduced
310
Closed
75

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$247M
2
XOM icon
ExxonMobil
XOM
+$200M
3
RTX icon
RTX Corp
RTX
+$193M
4
CVX icon
Chevron
CVX
+$182M
5
QCOM icon
Qualcomm
QCOM
+$166M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$642M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$349M
3
MSFT icon
Microsoft
MSFT
+$204M
4
MCD icon
McDonald's
MCD
+$183M
5
MRK icon
Merck
MRK
+$174M

Sector Composition

Rank Sector Weight
1 Technology 23.1%
2 Healthcare 22.91%
3 Consumer Staples 22.12%
4 Energy 7.11%
5 Communication Services 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMX icon
51
America Movil
AMX
$77.1B
$166M 0.4%
7,102,680
-679,260
-9% -$14.8M
LO
52
DELISTED
LORILLARD INC COM STK
LO
$165M 0.4%
3,257,512
-1,049,148
-24% -$52.3M
BIDU icon
53
Baidu
BIDU
$35.8B
$161M 0.39%
905,695
-239,655
-21% -$38.7M
WFC icon
54
Wells Fargo
WFC
$264B
$161M 0.39%
3,544,889
+1,889,600
+114% +$81.6M
GIS icon
55
General Mills
GIS
$19.5B
$153M 0.37%
3,056,119
-34,303
-1% -$1.71M
ELV icon
56
Elevance Health
ELV
$82.1B
$149M 0.36%
1,613,844
+936,942
+138% +$83.3M
EEM icon
57
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$134M 0.32%
3,205,439
-3,271,613
-51% -$137M
VALE icon
58
Vale
VALE
$62.9B
$133M 0.32%
8,728,370
-4,634,801
-35% -$72.1M
INTU icon
59
Intuit
INTU
$83.1B
$130M 0.32%
1,708,934
+188,364
+12% +$13.5M
ITW icon
60
Illinois Tool Works
ITW
$81.9B
$118M 0.29%
1,404,228
+1,030,428
+276% +$81.3M
TJX icon
61
TJX Companies
TJX
$173B
$113M 0.27%
3,536,836
-192,742
-5% -$5.84M
MON
62
DELISTED
Monsanto Co
MON
$108M 0.26%
929,629
+676,809
+268% +$73.9M
LH icon
63
Labcorp
LH
$24.7B
$102M 0.25%
1,298,173
-175,740
-12% -$15M
BBBY
64
DELISTED
Bed Bath & Beyond Inc
BBBY
$100M 0.24%
1,245,976
+149,103
+14% +$11.5M
MBT
65
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$96.6M 0.23%
4,464,285
-605,087
-12% -$13.3M
SKM icon
66
SK Telecom
SKM
$13.5B
$94.7M 0.23%
2,335,820
+506,785
+28% +$20M
C icon
67
Citigroup
C
$223B
$89.6M 0.22%
1,719,562
-720,201
-30% -$36.4M
ITUB icon
68
Itaú Unibanco
ITUB
$92.3B
$89.2M 0.22%
18,027,709
-5,759,369
-24% -$29.9M
CTSH icon
69
Cognizant
CTSH
$22.3B
$86.9M 0.21%
1,721,936
+840,612
+95% +$38.3M
ADBE icon
70
Adobe
ADBE
$94.5B
$85.1M 0.21%
1,421,584
+1,016,084
+251% +$56.1M
CNQ icon
71
Canadian Natural Resources
CNQ
$93.4B
$84.8M 0.21%
5,187,913
+4,902,661
+1,719% +$76.2M
COV
72
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$83.4M 0.2%
1,224,091
+659,786
+117% +$42.9M
HD icon
73
Home Depot
HD
$335B
$82.2M 0.2%
998,622
+344,199
+53% +$26.8M
AGN
74
DELISTED
Allergan Inc
AGN
$80.9M 0.2%
727,994
-175,167
-19% -$16.7M
BAC icon
75
Bank of America
BAC
$436B
$77.9M 0.19%
5,001,629
-2,297,019
-31% -$34.1M

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2013 Portfolio in Review

As of Q4 2013, Grantham, Mayo, Van Otterloo & Co (GMO) held 737 positions worth $41.2B, up 8.6% from $37.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2013 filing shows 74 new, 253 increased, 310 reduced and 75 closed positions. Its largest new stake was ICICI Bank: 3,782,900 shares worth $25.6M. The largest sale was Pfizer, an estimated $642M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q4 2013 buy was ICICI Bank: 3,782,900 shares worth $25.6M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to IBM in Q4 2013, an estimated $247M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q4 2013 reduction was Pfizer, cutting an estimated $642M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Vodafone in Q4 2013, selling an estimated $33.6M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 40% of its $41.2B portfolio in Q4 2013.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 74 new positions and closed 75 in Q4 2013.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 8.6% quarter-over-quarter to $41.2B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2013, filed 13 Feb 2014.